Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ABSK-121 by Abbisko Therapeutics for Solid Tumor: Likelihood of Approval
ABSK-121 is under clinical development by Abbisko Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...